To hear about similar clinical trials, please enter your email below
Trial Title:
Evaluation of a Patient 'Nudge' on Engagement in Lung Cancer Screening
NCT ID:
NCT06474611
Condition:
Lung Cancer
Conditions: Official terms:
Lung Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Active, not recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Other
Masking:
None (Open Label)
Masking description:
No masking involved. This is a quality improvement project where patients who have an
upcoming Primary Care visit receive an electronic or paper letter notification that they
qualify for lung cancer screening and that they should talk to their dr at the upcoming
visit.
Intervention:
Intervention type:
Behavioral
Intervention name:
Patient nudge
Description:
Patient receives an electronic or paper letter 'nudge' to talk to dr about LCS.
Arm group label:
Birth year = even AND active on KP.org
Arm group label:
Birth year = even AND not active on KP.org
Summary:
The purpose of this quality improvement project is to conduct and evaluate the effect of
sending an electronic reminder message to patients who qualify for lung cancer screening,
haven't had a screening previously, and who have an upcoming scheduled appointment with
their doctor.
Detailed description:
United States Preventive Services Task Force (USPSTF) lung cancer screening (LCS)
guidelines recommend LCS for those aged 50-80 with at least 20 pack-years smoking
history, who currently smoke or quit within the last 15 years. In 2023, our study team
found that there are approximately 6,000 - 8,000 Kaiser Permanente Colorado (KPCO)
members who are unscreened and eligible for lung cancer screening (LCS). In support of
KP's Population Health priority initiative to expand lung cancer screening participation
for those who are eligible, our study team was selected to move this work forward in 2024
with feasible implementation opportunities for the KPCO LCS Operational/Institute for
Health Research partnership at its core. The primary objective of this project is to
conduct and evaluate a randomized quality improvement pragmatic intervention of a 2-arm
electronic message outreach to unscreened LCS members who are eligible for LCS and who
have an upcoming scheduled Primary Care Provider (PCP) visit.
Criteria for eligibility:
Criteria:
Inclusion Criteria: Qualifies for Lung Cancer Screening based on USPSTF criteria (aged
50-80, at least 20 pack years smoking history, currently smoke or quit in the last 15
years); have an upcoming, scheduled Primary Care visit in a KP clinic in the coming 7-14
days, have not completed a low-dose CT scan.
Exclusion Criteria:
- None
Gender:
All
Minimum age:
50 Years
Maximum age:
80 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Kaiser Permanente
Address:
City:
Aurora
Zip:
80011
Country:
United States
Start date:
March 26, 2024
Completion date:
December 2024
Lead sponsor:
Agency:
Kaiser Permanente
Agency class:
Other
Source:
Kaiser Permanente
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06474611
